News for hackers. Stuff that matters.
Re:Lung cancer pill cuts risk of death by half by semenko on Sunday June 04, 2023 @10:04AM (#36185698)
Agreed! This specifically is for adjuvant osimertinib for EGFR+ Stage IB–IIIA completely resected NSCLC.

The headline here is really strong -- and the actual abstract is much more sober: "5-year OS rate was 88% with osimertinib vs 78% with placebo" [Full abstract is here: https://meetings.asco.org/abstracts-presentations/219805 ]

P.S. Hi Chris! (I think I picked up a summer student from you last week!)

Re:Lung cancer pill cuts risk of death by half by haldujai on Sunday June 04, 2023 @11:29AM (#36186377)
Very sober given the costs and %age of patients who didn’t receive adjuvant chemo in the initial trial.

Interested to see their detailed results but I’m mildly suspicious this will be AstraZeneca PR buffing underwhelming results.